Links -> Link Details
| Title | Astrazaneca’s $6 billion collaboration with Daiichi Sankyo for Commercializing DS-1062. |
|---|---|
| URL | https://mellalta.com/development-marketing-strategy-behind-daiichi-sankyos-ds-1062-6-billion-deal-with-astrazeneca/ |
| Category | Fitness Health --> Pharmacy |
| Meta Keywords | Non-Small Cell Lung cancer, Triple negative breast cancer, NCLC, TNBC, AstraZaneca, Daiichi Sankyo, Antibody drrug, DS1062, Oncology pipeline, antibody drug conjugate, ADC, TROP-2 |
| Meta Description | Daiichi Sankyo unveiled about the collaboration between them and AstraZeneca for antibody drug conjugate, DS-1062. This news has created absolute havoc in the Pharma market. |
| Owner | Emma Stones |
| Description | |
| Mellalta Meets LLP is a research-based consultancy with a global footprint. We have worked with firms around the world to help them optimize their business strategy and transform their business decisions | |